Vima Therapeutics (Series A)
Funding Details
- Awarder
- RSS - feeds.feedburner.com
- Date Award
- June 06, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $60,000,000
Company Info
- Company Description
- Vima Therapeutics is a clinical-stage biotechnology company focused on oral therapies for movement disorders, advancing VIM0423, a potential first-in-class oral therapy for dystonia that targets the underlying cause in the central nervous system.
- Market
- Movement Disorders
- Location
- Cambridge, MA, USA
- Coinvestors
- Access Industries, Canaan